Work

Immune related adverse events as a biomarker in non-melanoma patients treated with programmed death 1 inhibitors (PD-1Is).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.3069

Authors: Julia Judd, Matthew R. Zibelman, Elizabeth Handorf, John O'Neill, Sasini Bentota, Jamie Doyle, Robert G. Uzzo, Jessica Ruth Bauman, Hossein Borghaei, Elizabeth R. Plimack, Ranee Mehra, Daniel M. Geynisman

Institutions: Temple University Health System, Fox Chase Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890943068

Cites:

Cited by: 1

Related to: 10